History

July 1997
Founding of COMITATO SENDO in Milan (I) by:

Franco Cavalli, Istituto Oncologico della Svizzera Italiana, Bellinzona (CH)
Silvio Garattini, Istituto di Ricerche Farmacologiche Mario Negri, Milano (I)
Franco Rilke, Istituto Nazionale dei Tumori, Milano (I)
Umberto Veronesi, Istituto Europeo di Oncologia, Milano (I)

through the support of the FIRC (Fondazione Italiana per la Ricerca sul Cancro) and the National Cancer Institute, USA

November 1998
First early clinical trial initiated by SENDO.

José Baselga, Hospital General Vall d’Hebron, Barcelona joins SENDO

May 1999
SENDO, together with the CRC-DDO and EORTC-NDDP, founds the European Drug Development Network

Year 2000
SENDO opens up to researchers and clinical scientists from oncology centers throughout Italy, Switzerland and Spain

Year 2001
SENDO in a joint effort with the Fondo Edo Tempia, Biella (I) and with the support of the Regione Piemonte opens the Laboratory of Cancer Pharmacogenomics in Biella (I)

Year 2002
SENDO becomes a Foundation